I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Phase Ib Study of the Oral Proteasome Inhibitor Ixazomib (M..:
Schwartz, Gary
;
Shee, Kevin
;
Romo, Bianca
...
The Oncologist. 26 (2021) 6 - p. 467-e924 , 2021
Link:
https://doi.org/10.1002/onco.13733
RT Journal T1
Phase Ib Study of the Oral Proteasome Inhibitor Ixazomib (MLN9708) and Fulvestrant in Advanced ER+ Breast Cancer Progressing on Fulvestrant
UL https://suche.suub.uni-bremen.de/peid=cr-10.1002_onco.13733&Exemplar=1&LAN=DE A1 Schwartz, Gary A1 Shee, Kevin A1 Romo, Bianca A1 Marotti, Jonathan A1 Kisselev, Alexei A1 Lewis, Lionel A1 Miller, Todd PB Oxford University Press (OUP) YR 2021 SN 1083-7159 SN 1549-490X JF The Oncologist VO 26 IS 6 SP 467 OP e924 LK http://dx.doi.org/https://doi.org/10.1002/onco.13733 DO https://doi.org/10.1002/onco.13733 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)